Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Drugs
Drugs
Page 28 of 29
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By
Laura Lorenzetti
December 2, 2014
International
Merck buys the rights to an experimental Ebola vaccine
By
Reuters
November 24, 2014
Features
5 things that will kill you before Ebola does
By
Verne Kopytoff
October 30, 2014
International
Hands off our hookers’ and dope dealers’ money, U.K. tells E.U.
By
Geoffrey Smith
October 24, 2014
International
Spain gets a questionable GDP boost, thanks to drugs and prostitution
By
Ian Mount
October 8, 2014
International
Dallas Ebola patient gets experimental drug
By
TIME
October 7, 2014
Leadership
Fortune 5: The Biggest Organized Crime Groups in the World
By
Chris Matthews
September 14, 2014
Finance
Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug
By
Laura Lorenzetti
August 25, 2014
Finance
Pfizer facing growing number of lawsuits over Lipitor side effects
By
Laura Lorenzetti
August 8, 2014
Management
When corruption is good for the economy
By
Chris Matthews
August 7, 2014
Finance
Abbvie rakes in profit as investors look for assurance on Shire deal
By
Laura Lorenzetti
July 25, 2014
Features
Bristol-Myers profits beat estimates as it readies new immuno-harnessing cancer drug
By
Laura Lorenzetti
July 24, 2014
Finance
Allergan says it will cut 13% of its global workforce
By
Laura Lorenzetti
July 21, 2014
Management
FedEx charged with trafficking drugs for Internet pharmacies
By
Ben Geier
July 18, 2014
Finance
Vertex gets tangled in Medicaid lawsuit
By
Laura Lorenzetti
July 17, 2014
Most Popular
Conferences
Ray Dalio says America is developing a ‘dependency’ on the top 1% of workers, while the bottom 60% are struggling and...
By
Eleanor Pringle
Real Estate
Warren Buffett's Berkshire Hathaway and Zillow say mortgage rates can't fall enough for Americans to afford a home
By
Sydney Lake
Politics
Transportation secretary threatens to take $160 million from California over commercial driver’s licenses for...
By
The Associated Press